ASK REDCHAT ANYTHING ABOUT IMMUNEERING CORPORATION
Immuneering Corporation (NASDAQ: IMRX)
Listen to this Section
$4.27
-0.2150
(
-4.80% )
933.4K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| IMM-1-104DetailsSolid tumor/s, Cancer |
Phase 2a |
| IMM-6-415DetailsSolid tumor/s |
Phase 1/2 |
Market Data
|
| Open |
$4.27 |
| Previous Close |
$4.48 |
| Volume |
933.4K |
| Market Cap |
$294.37M |
| Day Range |
$4.21 - $4.60 |
| 52 Week Range |
$1.66 - $10.08 |
| Shares Outstanding |
64.70M |
| Change % |
-4.80% |
| Net Change |
▼ -0.2150 |
| Insider Ownership |
-0.01% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2021 |
| Country | United States |
| Underwriter | Morgan Stanley, Jefferies, TD Cowen, Guggenheim Securities, more |
Insider Ownership Transactions
Total Amount Purchased:
-1,247,132.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2025-10-07 |
Buy |
7500.00 |
Feinberg Peter |
| 2025-10-02 |
Buy |
1020.00 |
Bookman Michael |
| 2025-10-02 |
Buy |
1020.00 |
Bookman Michael |
| 2025-10-02 |
Buy |
800.00 |
Neufeld Leah R |
| 2025-10-02 |
Buy |
300.00 |
Morales Mallory |
| 2025-10-01 |
Buy |
7500.00 |
Feinberg Peter |
| 2025-10-01 |
Buy |
7500.00 |
Feinberg Peter |
| 2025-10-01 |
Buy |
7500.00 |
Feinberg Peter |
| 2025-09-30 |
Buy |
5000.00 |
Feinberg Peter |
| 2025-09-30 |
Buy |
5000.00 |
Feinberg Peter |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 4 |
Insider transactions |
1 |
Sep 17, 2025 |
| 4 |
Insider transactions |
1 |
Sep 17, 2025 |
| 4 |
Insider transactions |
1 |
Sep 17, 2025 |
| 8-k |
8K-related |
18 |
Aug 25, 2025 |
| 10-q |
Quarterly Reports |
65 |
Aug 13, 2025 |
| 8-k |
8K-related |
14 |
Aug 13, 2025 |
| 4 |
Insider transactions |
1 |
Jul 07, 2025 |
| 4 |
Insider transactions |
1 |
Jul 07, 2025 |
| 4 |
Insider transactions |
1 |
Jul 03, 2025 |
| 4 |
Insider transactions |
1 |
Jun 30, 2025 |